PTAB Agrees to Review Patent Claims Covering Dry Eye Ailments, PTAB Litigation Blog
Visit the PTAB Litigation Blog.
On December 8, 2016, the PTAB issued six institution decisions in cases IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132, agreeing to review claims of U.S. Patent Nos. 8,685,930, 8,629,111, 8,642,556, 8,633,162, 8,648,048, and 9,248,191. All six patents are owned by Allergan Inc. (“Allergan”) and challenged by Mylan Pharmaceuticals Inc. (“Mylan”).
